The hemolytic effect of primaquine V. Primaquine sensitivity as a manifestation of a multiple drug sensitivity.

No abstract is available for this paper.

• Publication year

  1981

• Venue

  Journal of Laboratory and Clinical Medicine

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.5555/URI:PII:0022214355900500PMID 7229509
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The hemolytic effect of primaquine. II. The natural course of the hemolytic anemia and the mechanism of its self-limited character.

  1954cited by this paper
• The hemolytic effect of primaquine. IV. The relationship of cell age to hemolysis.

  1954cited by this paper
• THE USE OF RADIOACTIVE SODIUM CHROMATE TO EVALUATE THE LIFE SPAN OF THE RED BLOOD CELL IN HEALTH AND CERTAIN HEMATOLOGIC DISORDERS

  1954cited by this paper
• The hemolytic effect of primaquine. I. The localization of the drug-induced hemolytic defect in primaquine-sensitive individuals.

  1954cited by this paper
• Radioactive sodium chromate for the study of survival of red blood cells. I. The effect of radioactive sodium chromate on red cells.

  1953cited by this paper
• The use of radioactive chromium 51 as an erythrocyte tagging agent for the determination or red cell survival in vivo.

  1953cited by this paper
• SULFOXONE (DIASONE®) SODIUM FOR DERMATITIS HERPETIFORMIS

  1951cited by this paper
• Sulfozone (diasone) sodium for dermatitis herpetiformis.

  1951cited by this paper
• [Pathogenesis of toxic hemolytic anemia following chronic phenacetin abuse].

  1950cited by this paper
• [Addenda to our knowledge on the pathogenesis of toxico-hemolytic anemia following the administration of phenacetin (saridon)].

  1950cited by this paper
• ANEMIA DURING SULFANILAMIDE THERAPY

  1938cited by this paper

• A campaign of mass drug administration with artemisinin-piperaquine to antimalaria in Trobriand Islands

  2023cites this paper
• G6PD Variants and Haemolytic Sensitivity to Primaquine and Other Drugs

  2021cites this paper
• Dapsone-Associated Hemolytic Anemia in Renal Transplant Recipients With Normal Glucose-6-Phosphate-Dehydrogenase Levels.

  2020cites this paper
• One-Pot Synthesis of 5-(Het)Aryl 8-Aminoquinoline Amide Derivatives as Potential Antibacterial / Cytotoxic Agents

  2020cites this paper
• Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria

  2019cites this paper
• Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria

  2019cites this paper
• Pathophysiology of allergic drug reactions.

  2019cites this paper
• Safety of single low-dose primaquine in glucose-6-phosphate dehydrogenase deficient falciparum-infected African males: Two open-label, randomized, safety trials

  2018cites this paper
• Safety of single low-dose primaquine in glucose-6-phosphate dehydrogenase deficient falciparum-infected African males: Two open-label, randomized, safety trials

  2018cites this paper
• Acute hemolysis in a patient with a newly diagnosed glioblastoma.

  2016cites this paper
• Development of HepG2-derived cells expressing cytochrome P450s for assessing metabolism-associated drug-induced liver toxicity.

  2016cites this paper
• Tolerability and safety of weekly primaquine against relapse of Plasmodium vivax in Cambodians with glucose-6-phosphate dehydrogenase deficiency

  2015cites this paper
• Noninferiority of glucose-6-phosphate dehydrogenase deficiency diagnosis by a point-of-care rapid test vs the laboratory fluorescent spot test demonstrated by copper inhibition in normal human red blood cells

  2015cites this paper
• The challenges of introducing routine G6PD testing into radical cure: a workshop report

  2015cites this paper
• Scalable Preparation and Differential Pharmacologic and Toxicologic Profiles of Primaquine Enantiomers

  2014cites this paper
• Field Trial Evaluation of the Performances of Point-of-Care Tests for Screening G6PD Deficiency in Cambodia

  2014cites this paper
• G6PD deficiency in Latin America: systematic review on prevalence and variants

  2014cites this paper
• Primaquine: the risks and the benefits

  2014cites this paper
• Pharmacokinetics and Pharmacodynamics of (+)-Primaquine and (−)-Primaquine Enantiomers in Rhesus Macaques (Macaca mulatta)

  2014cites this paper
• G6PD deficiency: a classic example of pharmacogenetics with on-going clinical implications

  2014cites this paper
• Genetic determinants of glucose-6-phosphate dehydrogenase activity in Kenya

  2014cites this paper
• First Evaluation of Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency in Vivax Malaria Endemic Regions in the Republic of Korea

  2014cites this paper
• G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests

  2013cites this paper
• Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop report

  2013cites this paper
• Primaquine to prevent transmission of falciparum malaria.

  2013cites this paper
• G6PD deficiency in Plasmodium falciparum and Plasmodium vivax malaria-infected Cambodian patients

  2013influential citation
• Spatial distribution of G6PD deficiency variants across malaria-endemic regions

  2013cites this paper
• INDIAN JOURNAL OF PRACTICAL PEDIATRICS • IJPP is a quarterly subscription journal of the Indian Academy of Pediatrics committed to presenting practical pediatric issues and management updates in a simple and clear manner

  2013cites this paper
• Biomarker und personalisierte Medizin

  2013cites this paper
• Antimalarial aminothiazoles and aminopyridines from phenotypic whole-cell screening of a SoftFocus(®) library.

  2012cites this paper
• Primaquine radical cure of Plasmodium vivax: a critical review of the literature

  2012cites this paper
• Pharmacogenomics in colorectal cancer: a genome-wide association study to predict toxicity after 5-fluorouracil or FOLFOX administration

  2012cites this paper
• Clinical spectrum and severity of hemolytic anemia in glucose 6-phosphate dehydrogenase-deficient children receiving dapsone.

  2012cites this paper
• A Review of Pharmacogenetics of Adverse Drug Reactions in Elderly People

  2012cites this paper
• Understanding the mechanisms for metabolism-linked hemolytic toxicity of primaquine against glucose 6-phosphate dehydrogenase deficient human erythrocytes: evaluation of eryptotic pathway.

  2012cites this paper
• Glucose-6-Phosphate Dehydrogenase Deficiency and Malaria: A Method to Detect Primaquine-Induced Hemolysis in vitro

  2012cites this paper
• AÇÃO DE DESFEROXAMINA E DEFERASIROX EM ERITRÓCITOS DE PORTADORES DE ANEMIAS DEPENDENTES DE TRANSFUSÃO, COM SOBRECARGA OXIDATIVA, IN VITRO

  2012cites this paper
• G6PD Deficiency Prevalence and Estimates of Affected Populations in Malaria Endemic Countries: A Geostatistical Model-Based Map

  2012cites this paper
• Performance of the CareStart™ G6PD Deficiency Screening Test, a Point-of-Care Diagnostic for Primaquine Therapy Screening

  2011cites this paper
• 8-Aminoquinolines: Primaquine and Tafenoquine

  2011cites this paper
• Determinants of relapse periodicity in Plasmodium vivax malaria

  2011cites this paper
• Ernest Beutler: his life and contribution to medical science

  2011cites this paper
• Review: Improving the therapeutic index of 8-aminoquinolines by the use of drug combinations: review of the literature and proposal for future investigations.

  2011cites this paper
• Consideration of ethics in primaquine therapy against malaria transmission.

  2011cites this paper
• The influence of genetics on response to treatment with ranibizumab (Lucentis) for age-related macular degeneration: the Lucentis Genotype Study (an American Ophthalmological Society thesis).

  2011cites this paper
• Epidemiology and Infectivity of Plasmodium falciparum and Plasmodium vivax Gametocytes in Relation to Malaria Control and Elimination

  2011cites this paper
• Medications and Glucose-6-Phosphate Dehydrogenase Deficiency

  2010cites this paper
• Resistance to Therapies for Infection by Plasmodium vivax

  2009cites this paper
• Effect of vitamin C, deferoxamine, quercetin and rutin against tert-butyl hydroperoxide oxidative damage in human erythrocytes

  2009cites this paper
• Hb Sogn (β14 Arginine)

  2009cites this paper
• Basics of Personalized Medicine

  2009cites this paper
• AÇÃO DE EXTRATO HIDROALCÓOLICO DE UVAS PRETAS (Vitis vinifera) EM ERITRÓCITOS HUMANOS E SOBRECARGA OXIDATIVA POR terc-BUTIL HIDROPERÓXIDO

  2008cites this paper
• Glucose-6-phosphate dehydrogenase deficiency: a historical perspective.

  2008cites this paper
• Glucose-6-phosphate dehydrogenase deficiency and antimalarial drug development.

  2007cites this paper
• Effect of vitamins C and E on oxidative processes in human erythrocytes

  2006cites this paper
• Acute Hemolytic Anemia in tile Newborii Infant due to Naphthalene Poisoiiing : Report of Two Cases , with Investigations ilito the Mechanism of the Disease By

  2005cites this paper
• STUDIES ON GLUTATHIONE STABILITY IN ERYTHROCYTES

  2005cites this paper
• Splenectomy may not influence glutathione metabolism in children with beta-thalassaemia major.

  2005cites this paper
• Zur Entstehung der medikamenteninduzierten Anämie bei Glutathionreduktase-Mangelträgern

  2005cites this paper
• Die Glutathionreduktion in Erythrocyten von Gesunden und Enzymdefektträgern

  2005cites this paper
• The genetic basis of variability in drug responses

  2002cites this paper
• Pharmacogenetics and Pharmacogenomics in

  2002cites this paper
• Anemia and the liver. Hepatobiliary manifestations of anemia.

  2002cites this paper
• Primaquine-Induced Hemolytic Anemia: Effect of 6-Methoxy-8-hydroxylaminoquinoline on Rat Erythrocyte Sulfhydryl Status, Membrane Lipids, Cytoskeletal Proteins, and Morphology

  2002cites this paper
• Glukose-6-Phosphat-Dehydrogenase-Mangel

  2001cites this paper
• Prevalence of G-6-PD deficiency in the Croatian Adriatic Coast population.

  2001cites this paper
• OXIDAÇÃO DA HEMOGLOBINA COMO MODELO DE ESTUDO DO SISTEMA DE ÓXIDO-REDUÇÃO ERITROCITÁRIO: INTERAÇÃO ENTRE NITRITO DE SÓDIO, AZUL DE METILENO E CISTAMINA.

  2001cites this paper
• Primaquine-induced hemolytic anemia: formation and hemotoxicity of the arylhydroxylamine metabolite 6-methoxy-8-hydroxylaminoquinoline.

  2001cites this paper
• Perspectives in pharmacogenetics.

  2001cites this paper
• Discrepancies between genotype and phenotype in hematology: an important frontier.

  2001cites this paper
• LOCATION OF POINT MUTATIONS IN G 6 PD DEFICIENCY

  2000cites this paper
• Hereditäre Membrandefekte und Enzymopathien roter Blutzellen

  2000cites this paper
• The Molecular Basis of a Case of γ-Glutamylcysteine Synthetase Deficiency

  1999cites this paper
• Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia.

  1997cites this paper
• G6PD: population genetics and clinical manifestations.

  1996cites this paper
• G6PD deficiency.

  1994cites this paper
• Anämien aufgrund von Störungen der Hämoglobinsynthese und -struktur

  1994cites this paper
• Drug-associated "bite cell" hemolytic anemia.

  1992cites this paper
• Glucose-6-phosphate dehydrogenase deficiency and sulfadimidin acetylation phenotypes in Egyptian oases

  1992cites this paper
• Glucose-6-phosphate dehydrogenase deficiency and sulfadimidin acetylation phenotypes in Egyptian oases

  1992cites this paper
• Role of genetics and drug metabolism in human cancer risk.

  1991cites this paper
• Glucose-6-phosphate dehydrogenase deficiency.

  1991cites this paper
• Glyoxalase activity in human red blood cells fractioned by age.

  1989cites this paper
• Susceptibility of glucose-6-phosphate dehydrogenase deficient red cells to primaquine enantiomers and two putative metabolites--I. Effect on reduced glutathione, methemoglobin content and release of hemoglobin.

  1988cites this paper
• The effects of ethanol on the hematotoxicity of environmental and pharmaceutical agents

  1988cites this paper
• Methemoglobinogenic potential of primaquine and its mutagenicity in the Ames test.

  1987cites this paper
• PHARMACOGENETIC INTERACTION OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY WITH ACETYLATION AND HYDROXYLATION

  1986cites this paper
• Erythrocyte Glucose-6-Phosphate Dehydrogenase Deficiency Does Not Pose an Increased Risk for Black Americans Exposed To Oxidant Gases in the Workplace or General Environment

  1985cites this paper
• Beta-glucuronidase-positive erythrocytic inclusion bodies--a hitherto unknown phenomenon.

  1985cites this paper
• Glucose 6-Phosphate dehydrogenase deficiency genetic, pathophysiological and therapeutic aspects.

  1985cites this paper
• Vitamin E and dapsone-induced hemolysis.

  1984cites this paper
• Microsomal incubation test of potentially hemolytic drugs for glucose‐6‐phosphate dehydrogenase deficiency

  1983cites this paper
• Nitrate, nitrite and N -nitroso compounds: biochemistry, metabolism, toxicity and carcinogenicity

  1982cites this paper
• Clinical Significance of Riboflavin Deficiency

  1980cites this paper
• Inherited erythrocyte metabolic and membrane disorders.

  1980cites this paper
• Effects of environmental oxidant stressors on individuals with a G-6-PD deficiency with particular reference to an animal model.

  1979cites this paper
• Triosephosphate isomerase deficiency with hemolytic anemia and severe neuromuscular disease. Familial and biochemical studies of a case found in Spain

  1978cites this paper
• Severe anemia due to transient pure red cell aplasia in early childhood

  1976cites this paper
• Hereditary hemolytic anemia with erythrocyte pyrimidine 5′-nucleotidase deficiency in Spain

  1976cites this paper
• Glucose phosphate isomerase deficiency with hereditary hemolytic anemia in a Spanish family: Clinical and familial studies

  1975cites this paper